Premium
Venoarterial extracorporeal membrane oxygenation as an early treatment for amniotic fluid embolism with cardiac arrest: A case report
Author(s) -
Adachi Mariko,
Adachi Takeshi,
Fujita Tomoe,
Hyuga Shunsuke,
Onishi Yoko,
Okutomi Toshiyuki
Publication year - 2021
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/jog.14880
Subject(s) - medicine , extracorporeal membrane oxygenation , amniotic fluid embolism , cardiopulmonary resuscitation , extracorporeal cardiopulmonary resuscitation , pulmonary embolism , cardiology , sudden cardiac arrest , anesthesia , resuscitation , pregnancy , biology , genetics
Amniotic fluid embolism (AFE) is a rare but fatal obstetric complication, characterized by sudden cardiovascular collapse, respiratory failure, and disseminated intravascular coagulation. Maternal mortality associated with AFE is high, making early recognition and prompt treatment important. In AFE with cardiac arrest, survival following acute cardiopulmonary dysfunction is crucial. In recent years, venoarterial extracorporeal membrane oxygenation (VA‐ECMO) has attracted attention as an aggressive treatment for AFE with cardiac arrest. A 40‐year‐old woman experienced sudden cardiac arrest due to AFE during cesarean section. Cardiopulmonary resuscitation and VA‐ECMO (also called percutaneous cardiopulmonary support) were initiated early. Finally, she recovered without any complications. VA‐ECMO can provide temporary respiratory and hemodynamic support until cardiopulmonary function improves after a few days in intensive care. VA‐ECMO should be considered as an early treatment for AFE with cardiac arrest.